Nautilus Biotechnology, Inc. (NAUT) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $13.00K; Additional Paid in CapitalUSD $492.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-331.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $13.00K; Additional Paid in CapitalUSD $491.21M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-91.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $13.00K; Additional Paid in CapitalUSD $488.74M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $243.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $13.00K; Additional Paid in CapitalUSD $487.17M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $200.00K.
Nautilus Biotechnology, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $13.00K | $492.62M | $-331.00K | $-361.19M | $131.11M | 3 month · $1.16M 6 month · $2.53M | (m) |
| 2026-03-31 | $0.00 | $13.00K | $491.21M | $-91.00K | $-346.72M | $144.41M | 3 month · $1.37M | (m) |
| 2025-12-31 | $0.00 | $13.00K | $488.74M | $243.00K | $-332.02M | $156.97M | 12 month · $6.84M | (m) |
| 2025-09-30 | $0.00 | $13.00K | $487.17M | $200.00K | $-318.24M | $169.14M | 3 month · $1.50M 9 month · $5.37M | (m) |
| 2025-06-30 | $0.00 | $13.00K | $485.67M | $77.00K | $-304.67M | $181.09M | 3 month · $1.71M 6 month · $3.88M | (m) |
| 2025-03-31 | $0.00 | $13.00K | $483.87M | $189.00K | $-289.63M | $194.44M | 3 month · $2.17M | (m) |
| 2024-12-31 | $0.00 | $13.00K | $481.68M | $57.00K | $-273.02M | $208.73M | 12 month · $12.70M | (m) |
| 2024-09-30 | $0.00 | $13.00K | $478.12M | $731.00K | $-255.43M | $223.43M | 3 month · $3.18M 9 month · $9.58M | (m) |
| 2024-06-30 | $0.00 | $13.00K | $474.79M | $-546.00K | $-238.98M | $235.28M | 3 month · $3.28M 6 month · $6.39M | (m) |
| 2024-03-31 | $0.00 | $13.00K | $471.19M | $-745.00K | $-220.97M | $249.49M | 3 month · $3.11M | (m) |
| 2023-12-31 | $0.00 | $13.00K | $467.83M | $-255.00K | $-202.24M | $265.35M | 12 month · $12.14M | (m) |
| 2023-09-30 | $0.00 | $12.00K | $464.51M | $-2.03M | $-185.22M | $277.27M | 3 month · $3.11M 9 month · $9.06M | (m) |
| 2023-06-30 | $0.00 | $12.00K | $461.39M | $-2.39M | $-169.34M | $289.67M | 3 month · $3.10M 6 month · $5.96M | (m) |
| 2023-03-31 | $0.00 | $12.00K | $458.19M | $-959.00K | $-153.53M | $303.71M | 3 month · $2.86M | (m) |
| 2022-12-31 | $0.00 | $12.00K | $455.33M | $-1.85M | $-138.56M | $314.92M | 12 month · $10.38M | (m) |
| 2022-09-30 | $0.00 | $12.00K | $452.36M | $-1.88M | $-125.16M | $325.34M | 3 month · $2.87M 9 month · $7.55M | (m) |
| 2022-06-30 | $0.00 | $12.00K | $449.41M | $-768.00K | $-111.09M | $337.56M | 3 month · $2.57M 6 month · $4.68M | (m) |
| 2022-03-31 | $0.00 | $12.00K | $446.65M | $-554.00K | $-96.40M | $349.71M | 3 month · $2.11M | (m) |
| 2021-12-31 | $0.00 | $12.00K | $444.39M | $-184.00K | $-80.64M | $363.58M | 12 month · $7.93M | (m) |
| 2021-09-30 | $0.00 | $12.00K | $441.80M | $-9.00K | $-63.95M | $377.85M | 3 month · $2.25M 9 month · $5.40M | (m) |
| 2021-06-30 | $0.00 | $12.00K | $439.49M | $-10.00K | $-49.45M | $390.04M | 3 month · $1.82M 6 month · $3.16M | (m) |
| 2021-03-31 | $0.00 | (m) | $7.29M | (m) | $-2.29M | $-36.80M | 3 month · $1.34M | (m) |
| 2020-12-31 | $0.00 | $1.00K | $600.00K | $3.00K | $-30.32M | $-29.72M | 12 month · $369.00K | 9 month · $8.76M |
| 2020-09-30 | $0.00 | (m) | $5.17M | (m) | $-170.71K | $-24.62M | 3 month · $59.00K 9 month · $119.00K | 3 month · $8.76M |
| 2020-06-30 | $0.00 | (m) | $24.63K | (m) | $-11.72K | $-20.73M | 3 month · $41.00K 6 month · $60.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-17.39M | (m) | (m) |
| 2020-03-26 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-14.51M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |